COMPANY NAME	REVENUES 12 Months Ending Q2 2022	MARKET SHARE 12 Months Q2 2022	MARKET SHARE MRQ Q2 2022	MARKET SHARE A Quarter Before Q1 2022
La Jolla Pharmaceutical Company	46.49	67.61%	0.00 %	0.00 %
Capricor Therapeutics inc	22.27	32.39%	0.00%	0.00%

LJPC's Market share relative to its competitors, as of Q2 2022 within the Healthcare Sector

As of Q2 2022

COMPANY NAME	MARKET SHARE 12 Months Ending Q2 2022	MARKET SHARE 12 Months Ending Q1 2022	MARKET SHARE MRQ Q2 2022	MARKET SHARE Q1 2022
La Jolla Pharmaceutical Company	67.61%	70.02%	100.00 %	100.00 %
Capricor Therapeutics inc	32.39%	29.98%	0.00%	0.00%

Note: Market share is calculated based on total revenue. To get a more accurate picture of La Jolla Pharmaceutical Company's market divisions, geographic dispersion, segments, products, and services, visit La Jolla Pharmaceutical Company's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.